NLRP3 and type 1 diabetes mellitus: We also demonstrated that NLRP3 inflammasome activation by mitochondrial DNA promotes IL-1β and IL-18 release, contributing to the generation of pathogenic Th17/Th1 cells in the PLNs and increasing T1D susceptibility in STZ-induced diabetes [22].